• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维蛋白原和血管性血友病因子对糖蛋白IIIa配体诱导结合位点的选择性诱导作用。

Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.

作者信息

Mondoro T H, Wall C D, White M M, Jennings L K

机构信息

Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda MD, USA.

出版信息

Blood. 1996 Nov 15;88(10):3824-30.

PMID:8916946
Abstract

Ligand-induced binding sites (LIBS) are neoantigenic regions of glycoprotein (GP)IIb-IIIa that are exposed upon interaction of the receptor with the ligand fibrinogen or the ligand recognition sequence (RGDS). LIBS have been suggested to contribute to postreceptor occupancy events such as full-scale platelet aggregation, adhesion to collagen, and clot retraction. This study examined the induction requirements of a GPIIIa LIBS with regard to ligand specificity. Through the use of the anti-LIBS D3, we report that this complex-activating antibody induces fibrinogen- and von Willebrand factor-binding to GPIIb-IIIa on intact platelets. Bound ligand was detected by flow cytometric analysis and platelet aggregation assays. These bound ligands increased the number of D3-binding sites and altered the affinity of D3 for GPIIb-IIIa on platelets. In contrast, activation of platelet GPIIb-IIIa by D3 did not increase the binding of another RGD-containing ligand, vitronectin. Furthermore, bound vitronectin on thrombin-stimulated platelets did not cause the expression of the D3 LIBS epitope. We conclude direct activation of GPIIb-IIIa in the absence of platelet activation results in selective ligand interaction and that D3 LIBS induction requires the binding of the multivalent ligands, fibrinogen or von Willebrand factor. Thus, the region of GPIIIa recognized by D3 may be an important regulatory domain in ligand-receptor interactions that directly mediate platelet aggregation.

摘要

配体诱导结合位点(LIBS)是糖蛋白(GP)IIb-IIIa的新抗原区域,当该受体与配体纤维蛋白原或配体识别序列(RGDS)相互作用时暴露出来。LIBS被认为有助于受体占据后的事件,如全面的血小板聚集、与胶原蛋白的粘附以及凝块回缩。本研究考察了GPIIIa LIBS在配体特异性方面的诱导需求。通过使用抗LIBS D3,我们报告这种复合物激活抗体可诱导纤维蛋白原和血管性血友病因子与完整血小板上的GPIIb-IIIa结合。通过流式细胞术分析和血小板聚集试验检测结合的配体。这些结合的配体增加了D3结合位点的数量,并改变了D3对血小板上GPIIb-IIIa的亲和力。相比之下,D3对血小板GPIIb-IIIa的激活并未增加另一种含RGD的配体玻连蛋白的结合。此外,凝血酶刺激的血小板上结合的玻连蛋白并未导致D3 LIBS表位的表达。我们得出结论,在没有血小板激活的情况下直接激活GPIIb-IIIa会导致选择性配体相互作用,并且D3 LIBS的诱导需要多价配体纤维蛋白原或血管性血友病因子的结合。因此,D3识别的GPIIIa区域可能是配体-受体相互作用中直接介导血小板聚集的重要调节结构域。

相似文献

1
Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.纤维蛋白原和血管性血友病因子对糖蛋白IIIa配体诱导结合位点的选择性诱导作用。
Blood. 1996 Nov 15;88(10):3824-30.
2
[Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].[抗糖蛋白IIIa N端片段单克隆抗体刺激下血小板膜糖蛋白IIb-IIIa复合物的构象变化]
Biokhimiia. 1996 Mar;61(3):412-28.
3
Interspecies comparison of platelet aggregation, LIBS expression and clot retraction: observed differences in GPIIb-IIIa functional activity.血小板聚集、LIBS表达和血块回缩的种间比较:观察到的糖蛋白IIb-IIIa功能活性差异。
Thromb Haemost. 1995 Dec;74(6):1551-6.
4
Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists.糖蛋白IIb-IIIa配体识别肽和肠外拮抗剂对配体诱导结合位点(LIBS)的差异表达
Thromb Haemost. 2000 Dec;84(6):1095-102.
5
Active GPIIb-IIIa conformations that link ligand interaction with cytoskeletal reorganization.将配体相互作用与细胞骨架重组联系起来的活性糖蛋白IIb-IIIa构象。
Blood. 2000 Oct 1;96(7):2487-95.
6
Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.血管性血友病因子可通过与活化的糖蛋白IIb-IIIa和糖蛋白Ib相互作用来支持血小板聚集。
Platelets. 2004 Nov;15(7):419-25. doi: 10.1080/09537100410001721333.
7
Stimulation of platelet glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa.用针对糖蛋白IIIa N端区域的单克隆抗体刺激血小板糖蛋白IIb-IIIa(αIIbβ3整合素)的功能活性。
FEBS Lett. 1996 Aug 5;391(1-2):84-8. doi: 10.1016/0014-5793(96)00709-0.
8
Ligand-binding assays: fibrinogen.
Methods Mol Biol. 2004;273:125-38. doi: 10.1385/1-59259-783-1:125.
9
Ability of different glycoprotein IIb-IIIa ligands to support platelet aggregation induced by activating antibody CRC54.不同糖蛋白IIb-IIIa配体支持激活抗体CRC54诱导血小板聚集的能力。
Biochemistry (Mosc). 2005 Jul;70(7):782-9. doi: 10.1007/s10541-005-0184-2.
10
A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.糖蛋白(GP)IIIa富含半胱氨酸结构域中的一个点突变导致表达一种锁定在高亲和力状态的GPIIb-IIIa(αIIbβ3)整合素受体以及类似血小板无力症的表型。
Blood. 2001 Oct 15;98(8):2432-41. doi: 10.1182/blood.v98.8.2432.

引用本文的文献

1
An αIIbβ3 monoclonal antibody traps a semiextended conformation and allosterically inhibits large ligand binding.一种 αIIbβ3 单克隆抗体捕获半延伸构象并变构抑制大配体结合。
Blood Adv. 2024 Aug 27;8(16):4398-4409. doi: 10.1182/bloodadvances.2024013177.